Use of flavone compound for prevention or treatment of obesity

摘要

The present invention relates to a pharmaceutical composition containing flavone compound as an active ingredient for treating obesity, and more specifically to a pharmaceutical composition for preventing or treating obesity and a dietary composition for preventing or reducing obesity containing 5,7-dimethoxyflavone or 5,7,4′-trimethoxyflavone. The compound according to the present invention inhibits adipogenesis, and reduces expression of the key transcription factors (SREBP1c and C/EBP) related to lipogenesis and of enzyme proteins (FAS and ACC) related to adipogenesis, and thus is effective in preventing or treating obesity.

主权项

1. A method for treating obesity, the method comprising administering an effective amount of a compound represented by Formula 1 or a salt thereof to a subject in need of obesity treatment wherein each of R1, R2, and R3 consists of hydrogen or a methoxy croup.